株式市場ニュース
最新の金融ニュース · 更新 7月 24, 2026
Acuta CapitalはErasca (ERAS)に賭け、354,575株を購入してがん治療をターゲットに
Acuta Capital Bet on Erasca (ERAS) and Targeted Cancer Treatments With a 354,575 Share Buy
Despite Acuta Capital's significant investment, the panel is largely bearish due to ERAS-0015 trial's patient death, high cash burn rate, …
Kailera TherapeuticsはIPO後の買いか？
Is Kailera Therapeutics a Buy After Its Sizzling IPO?
Kailera Therapeutics' IPO is considered high-risk due to intense competition, lack of approved products, and substantial clinical and regulatory risks. …
CEOが125,000株を購入した後、LegalZoom株は買いか？
Is LegalZoom Stock a Buy After the CEO Purchased 125,000 Shares?
Despite a CEO buy signal, the panel is largely bearish due to LegalZoom's eroding moat from AI disruption, anemic margins, …
グレッグ・エイベルは、おそらくウォーレン・バフェットのお気に入りの株式を購入しています。あなたも購入すべきでしょうか？
Greg Abel Is Buying Shares of What Is Probably Warren Buffett's Favorite Stock. Should You Buy It Too?
Panelists generally agree that Berkshire Hathaway's current cash hoard and buyback activity signal a defensive posture rather than a growth …
Patient Square、Nektar Pharmaceuticals (NKTR)の株式210,000株を購入し、大型投資を実行
Patient Square Makes a Big Bet on Nektar Pharmaceuticals (NKTR) Purchasing 210,000 Shares
Panelists generally agree that Patient Square's investment in NKTR signals confidence in Rezolve-AD's Phase 2b results, but they caution about …
ウォーレン・バフェットは何年も前からこう言っている。そのアドバイスを実践する1つのバンガードETF。
Warren Buffett Has Been Saying This for Years. 1 Vanguard ETF Puts That Advice Into Practice.
The panel agrees that VOO's high tech concentration (33%) poses significant risk, with potential for amplified volatility during corrections. They …
イプセン：眼窩皺における迅速かつ持続的な有効性を実証するコラボターゼデータ
Ipsen : Corabotase Data Demonstrate Rapid, Durable Efficacy In Glabellar Lines
Ipsen's corabotase shows promising Phase II data with rapid onset and strong 24-week durability versus Dysport, but Phase III results …
WaterBridge株は、Ranger Investmentが保有株を345,000株増やした後、買いか？
Is WaterBridge Stock a Buy After Ranger Investment Raised Its Stake by 345,000 Shares?
Despite Gemini's 'regulatory moat' argument, the panel consensus is bearish due to WaterBridge's high debt, lack of consistent profitability, and …
LimeがIPOを申請 -- 代わりにこちら株を買おう
Lime Filed for an IPO -- Buy This Stock Instead
The panel consensus is bearish on Lime's IPO, citing the 'going concern' warning, Lime's debt maturity, and the risk of …
nVent Electric、5億ドルの自社株買いプログラムを承認
NVent Electric Board Approves $500 Mln Share Repurchase Program
The panel is neutral on NVT's $500M, 3-year buyback program. While the program is shareholder-friendly, the delayed start and lack …
あなたの社会保障給付金は、このルールを無視すると予想よりも少なくなる可能性があります
Your Social Security Benefit Could Be Smaller Than You Expect if You Ignore This Rule
The panel discusses the Social Security earnings test, highlighting its immediate liquidity crisis for lower-income retirees and the double penalty …
ヘッジファンドDelta Globalはアバクロンビー&フィッチ株式のポジションを解消しました。投資家にとってそれは何を意味するのでしょうか。
Hedge Fund Delta Global Exited Its Stake in Abercrombie & Fitch Stock. Here's What That Means for Investors.
The panel consensus is bearish on ANF, citing a forward P/E of 7x, potential margin compression, and lack of clear …